Zika virus and dengue virus are very close relatives. Both are mosquito-borne flaviviruses, and both specialize in infecting ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

Discover Corvus Pharmaceuticals' Q4 2024 earnings insights, highlighting soquelitinib's trial progress, upcoming milestones for 2025, and robust ...

The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American Society of Hematology (ASH) Annual Meeting 2024 showing that ICT01 administered ...

BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...

Learn more about the role of Tuberculosis in cancer and how a simple vaccine supports the immune system to fight it.

MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was ...

Researchers have shed new light on how tissues in the body are repaired following the damage and premature death of tissue ...

A new treatment is being trialled in Newcastle which could 'switch off' the immune response that causes rheumatoid arthritis.

Zika virus and dengue virus are very close relatives. Both are mosquito-borne flaviviruses, and both specialize in infecting ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

The HZI team has developed an AI-powered computer model that, for the first time, reveals the aging process at the cellular ...